Clinical Trial Update: Botulinum Toxin Injection in the UES for R-CPD [Phase 4]

View source ↗

Summary

Phase 4 study evaluating botulinum toxin injections into the upper esophageal sphincter for retrograde cricopharyngeus dysfunction (R-CPD); sponsor AZ Delta; st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retrograde Cricopharyngeus Dysfunction

Drugs mentioned

• Botulinum toxin injection into the upper esophageal sphincter (Botulinum toxin type A)

Snippet

Sponsor: AZ Delta | Conditions: Retrograde Cricopharyngeus Dysfunction | Phase 4 | Status: ACTIVE_NOT_RECRUITING